- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01955330
Long Term Follow-up Hybrid Revascularization
November 2, 2018 updated by: Lawson Health Research Institute
Long Term Follow-up of Robotic Hybrid Surgical Revascularization With CT Angiography
OBJECTIVES:
The objectives of the year study are two-fold:
- To determine the 5-7 year patency rate (rate of open bypass grafts) of the LITA graft and stent of patients who have already had robotically-assisted Hybrid CABG surgery using CTA and MPS-MIBI.
- To determine patient quality of life at 5-7 years after robotically-assisted Hybrid CABG surgery
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
New techniques such as robotically-assisted Hybrid CABG surgery need proper evaluation to ensure potential benefits gained are not harmful to that which we know to be of significant benefit to the patients, that being the left internal thoracic artery (LITA) graft (one of the main coronary arteries supplying your heart with blood).
We are therefore proposing a 5-7 year CT-Angiography (CTA) and Myocardial Perfusion Scintigraphy (MPS-MIBI) to assess the patency rate of the LITA graft and the stented graft in patients that have already undergone robotically assisted Hybrid CABG.
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 5A5
- London Health Sciences Centre, University & Victoria Hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients that have previously had Hybrid robotic coronary artery revascularization performed approximately 5-7 years ago at the London Health Sciences Centre, University Hospital by Dr. Kiaii.
Description
Inclusion Criteria:
- Patients that have previously had Hybrid robotic coronary artery revascularization performed approximately 5-7 years ago at the London Health Sciences Centre, University Hospital by Dr. Kiaii.
Exclusion Criteria:
- Patients not described above
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Hybrid robotic cabg patients
Postoperative (5-7 years)Hybrid CABG robotically assisted surgical revascularization patients
|
Lita to LAD performed by robot, Hybrid stent to other diseased coronary artery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Graft patency
Time Frame: 5-7 years post Hybrid surgery
|
To assess the graft patency of the LITA to LAD performed by the robot and the patency of the Stent.
|
5-7 years post Hybrid surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2013
Primary Completion (Actual)
September 1, 2017
Study Completion (Actual)
September 1, 2018
Study Registration Dates
First Submitted
September 27, 2013
First Submitted That Met QC Criteria
September 27, 2013
First Posted (Estimate)
October 7, 2013
Study Record Updates
Last Update Posted (Actual)
November 6, 2018
Last Update Submitted That Met QC Criteria
November 2, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kiaii-LTFUP-Hybrid-2013
- REB #15000 (Other Identifier: Lawson Health Research Institute)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaRecruitingCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationKorea, Republic of
Clinical Trials on Robotic Hybrid coronary artery revascularization
-
Tomsk National Research Medical Center of the Russian...TerminatedCoronary Artery DiseaseRussian Federation
-
Silesian Centre for Heart DiseasesMinistry of Science and Higher Education, PolandCompletedCoronary Artery Disease | Coronary Disease | Heart Disease | Myocardial IschaemiaPoland
-
Shanghai Jiao Tong University School of MedicineUnknownHeart Failure Due to Coronary Artery DiseaseChina
-
Jessa HospitalRecruitingCoronary Artery DiseaseBelgium
-
Rigshospitalet, DenmarkUniversitaire Ziekenhuizen KU Leuven; UMC Utrecht; Copenhagen Trial Unit, Center...Not yet recruitingCoronary Artery Disease
-
Emilia BagiellaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaRecruitingCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationKorea, Republic of
-
InCor Heart InstituteBoston Scientific CorporationUnknownMultivessel Coronary Artery DiseaseBrazil
-
The University of Texas Health Science Center,...TerminatedIschemic Heart DiseaseUnited States